As such, COX-2 overexpression leads to cancer cell proliferation, neovascularization, and suppression of apoptosis and thus is associated with a worse prognosis in various malignancies, especially sarcomas [14,15,16]. This evidence concerns the gene PTGS2 and sarcoma.